Gene · 4773
Papers3,204
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
161 to 180 of 3,204
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Time-resolved role of P2X4 and P2X7 during CD8+ T cell activation. | Front Immunol | 2024 | 38426095 | PubTator, text mining | PubMed |
| Nsp1 facilitates SARS-CoV-2 replication through calcineurin-NFAT signaling. | mBio | 2024 | 38411085 | PubTator, text mining | PubMed |
| NFATc2 promotes lactate and M2 macrophage polarization through USP17 in lung adenocarcinoma. | Anticancer Drugs | 2024 | 38386130 | PubTator, text mining | PubMed |
| NFAT signaling is indispensable for persistent memory responses of MCMV-specific CD8+ T cells. | PLoS Pathog | 2024 | 38346075 | PubTator, text mining | PubMed |
| IP3R1-mediated MAMs formation contributes to mechanical trauma-induced hepatic injury and the protective effect of melatonin. | Cell Mol Biol Lett | 2024 | 38308199 | PubTator, text mining | PubMed |
| Inhibition of protein arginine methyltransferase 6 activates interferon signaling and induces the apoptosis of endometrial cancer cells via histone modification. | Int J Oncol | 2024 | 38299254 | PubTator, text mining | PubMed |
| Single nuclei transcriptomics in human and non-human primate striatum in opioid use disorder. | Nat Commun | 2024 | 38296993 | PubTator, text mining | PubMed |
| Effect of aging on the human myometrium at single-cell resolution. | Nat Commun | 2024 | 38296945 | PubTator, text mining | PubMed |
| Updates on WHO classification for small round cell tumors: Ewing sarcoma vs. everything else. | Hum Pathol | 2024 | 38280658 | PubTator, text mining | PubMed |
| Integrated compact regulators of protein activity enable control of signaling pathways and genome-editing in vivo. | Cell Discov | 2024 | 38263404 | PubTator, text mining | PubMed |
| Integrated analysis of RNA-seq datasets reveals novel targets and regulators of COVID-19 severity. | Life Sci Alliance | 2024 | 38262689 | PubTator, text mining | PubMed |
| Identification and validation of CRLF1 and NRG1 as immune-related signatures in hypertrophic scar. | Genomics | 2024 | 38262564 | PubTator, text mining | PubMed |
| Combined Transcriptomics and Metabolomics Identify Regulatory Mechanisms of Porcine Vertebral Chondrocyte Development In Vitro. | Int J Mol Sci | 2024 | 38256262 | PubTator, text mining | PubMed |
| ZMIZ2 facilitates hepatocellular carcinoma progression via LEF1 mediated activation of Wnt/β-catenin pathway. | Exp Hematol Oncol | 2024 | 38254216 | PubTator, text mining | PubMed |
| Report and literature review of four cases of EWSR1::NFATC2 round cell sarcoma. | Diagn Pathol | 2024 | 38254207 | PubTator, text mining | PubMed |
| Negative prognostic behaviour of PD-L1 expression in tongue and larynx squamous cell carcinoma and its significant predictive power in combination with PD-1 expression on TILs. | BMC Immunol | 2024 | 38229027 | PubTator, text mining | PubMed |
| Uncovering hidden cancer self-dependencies through analysis of shRNA-level dependency scores. | Sci Rep | 2024 | 38195844 | PubTator, text mining | PubMed |
| Current views on selenoprotein S in the pathophysiological processes of diabetes-induced atherosclerosis: potential therapeutics and underlying biomarkers. | Diabetol Metab Syndr | 2024 | 38172976 | PubTator, text mining | PubMed |
| The chemokine receptor CXCR3 promotes CD8+ T cell-dependent lung pathology during influenza pathogenesis. | Sci Adv | 2024 | 38170765 | PubTator, text mining | PubMed |
Corrigendum to "RNF125, transcriptionally regulated by NFATC2, alleviates osteoarthritis via inhibiting the Wnt/β-catenin signaling pathway through degrading TRIM14" [Int. Immunopharmacol. 125 (2023) 111191]. | Int Immunopharmacol | 2024 | 38142206 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4773/papers?page=9